PASTEUR Act of 2023
The PASTEUR Act of 2023 creates a subscription model to incentivize development of new antimicrobial drugs to combat antibiotic resistance. It establishes a Committee on Critical Need Antimicrobials and a Critical Need Antimicrobial Advisory Group to identify priority infections and evaluate drug characteristics like treating multi-drug resistant infections or having novel mechanisms of action. The bill authorizes the Secretary to enter into subscription contracts with drug developers for up to $3 billion per contract, with payments based on specific drug characteristics. Drug developers receiving these contracts must meet requirements including ensuring commercial availability, tracking resistance data, and developing appropriate use plans. The act allocates $6 billion for fiscal year 2024 to fund these initiatives.
Bill status
in committee
1 of 4 stages cleared
Introduction
Apr 2023
Committee Review
Floor Vote
President
Introduced Apr 27, 2023
Last action Apr 27, 2023
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
Apr 27, 2023
Committee
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
upper
Apr 27, 2023
Introduced
Introduced in Senate
upper
1 primary · 7 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about S 1355
Scope: US
Hi! I can help you understand S 1355. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline